Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > If only we were a US or European company !
View:
Post by Oden6570 on Aug 14, 2024 2:47am

If only we were a US or European company !

Theralase was asked to divert attention to Bird Flue vaccine research by Canadaian Federal agency with O $$$ funds provided to date ! However in the US for instance support accomanies Goverment request. Roger Buffalo not far away relocate before next PP and call TLT an american company. 

Based on the latest research detailing RuvidarTM's success in the destruction of various viruses, the Company has gained consensus from the National Microbiology Laboratory to direct its research away from the Covid-19 virus vaccine to develop this technology for an avian influenza vaccine."

2024-06-04 | Theralase(R) Technology Effective in Virus Inactivation | TSXV:TLT | Press Release (stockhouse.com)


July 2 (Reuters) - The U.S. government has awarded $176 million to Moderna (MRNA.O), opens new tab to advance development of its bird flu vaccine, the company said on Tuesday, as concerns rise over a multi-state outbreak of H5N1 virus in dairy cows and infections of three dairy workers since March.
Funds from the U.S. Biomedical Advanced Research and Development Authority will be used to complete late-stage development and testing of a pre-pandemic mRNA-based vaccine against H5N1 avian influenza.
Bird flu concern prompts US to award Moderna $176 million for vaccine development | Reuters

 
Comment by Oilminerdeluxe on Aug 14, 2024 3:18am
Perhaps BTD in itself won't bring a giant re-rating, but it should open the door for partnerships that will? At least it sounds like we are close to applying for it. To get a GBM trial going, that will bring a re-rating if results are good imho. But we need the money for it first of course. 
Comment by Lesalpes29 on Aug 14, 2024 8:08am
We could partner with Pfizer no? We have the solution and they have the money. It seems easy! GL
Comment by Gooseybear on Aug 14, 2024 11:23am
Pfizer and other big pharmaceutical companies are in bed with the FDA. Big pharma waits until small companies run out of money because of FDA slow walking the process. Then they swoop up and take the product. I've seen it happen before. One of my promising small pharma stocks went BK and within the week, FDA approved the product and it was sold to a big pharmaceutical company while investors ...more  
Comment by gojotv! on Aug 14, 2024 12:36pm
Luckily, TLT will always find new money. And we're "Fast track"ed...So, relax. We can easily do this without selling out.
Comment by menoalittle on Aug 14, 2024 3:16pm
Take that crappy attitude and negative chit elsewhere, gooseybear.  It's been brought up spouted by some "caring" soul here way too many times and too often for me to even care to mention.  Maybe you're too small peanuts to think otherwise, but I'm of the opinion that there are enough intelligence and wealth behind and backing this company to take it across the ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250